Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00OEG
|
|||
| Former ID |
DCL000960
|
|||
| Drug Name |
RhTPO
|
|||
| Synonyms |
TPIAO (TN)
Click to Show/Hide
|
|||
| Indication | Idiopathic thrombocytopenic purpura [ICD-11: 3B64.10; ICD-10: D69; ICD-9: 287.31] | Discontinued in Phase 3 | [1] | |
| Company |
Pharmacia; Pfizer
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Thrombopoietin receptor (MPL) | Target Info | Agonist | [1] |
| KEGG Pathway | Cytokine-cytokine receptor interaction | |||
| Jak-STAT signaling pathway | ||||
| WikiPathways | Platelet Aggregation (Plug Formation) | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Emerging drugs for idiopathic thrombocytopenic purpura in adults. Expert Opin Emerg Drugs. 2008 Jun;13(2):237-54. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.